Fact CheckerSign in

NCT06136026Not yet recruiting

Integrated Chinese and Western Medicine Specialized Disease Cohort for Colorectal Cancer

Integrative Chinese and Western Medicine for Colorectal Cancer: A Nationwide Prospective Cohort Study

Source: ClinicalTrials.gov · Last updated 18 Nov 2023 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This is a nationwide cohort study on integrated traditional Chinese and Western medicine for colorectal cancer. The aim is to elucidate the distribution patterns of TCM syndromes in colorectal cancer and colorectal adenoma, reveal the relationship between TCM syndromes and diagnosis, prognosis, and prognosis. Based on biological samples, a phenotypic omics study of TCM syndromes in colorectal cancer and colorectal adenoma is conducted.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
50000 (estimated)
First submitted
6 Nov 2023
Start date
1 Dec 2023
Primary completion date
31 Dec 2028
Lead sponsor
Jiangsu Famous Medical Technology Co., Ltd.
NCT number
NCT06136026

What you commit to

  • Study type: Observational
  • Planned participants: 50000
  • From 1 Dec 2023 to the primary completion date, 31 Dec 2028
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Combined with other malignant tumors;
  • The patient has severe cognitive impairment, dementia, and various mental disorders.
    • Colorectal adenoma patients:
  • The patient had a history of malignancy;
  • The patient has severe cognitive impairment, dementia, and various mental disorders.

Other

  • CRC patients:

Who the study is looking for

  • CRC patients:
  • The patient is over 18 years old;
  • The patient meets the diagnostic criteria for colorectal cancer;
  • The patient has not received anti-tumor treatment such as surgery, chemotherapy, radiotherapy, targeted therapy, or immunity in the past;
  • The patient voluntarily participated in this study and signed an informed consent form.
    • Colorectal adenoma patients
  • The patient is over 18 years old;
  • The patient meets the diagnostic criteria for colorectal adenoma;
  • The patient voluntarily participated in this study and signed an informed consent form.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.